Riham Bokhtia | Molecular | Editorial Board Member

Editorial Board Member

  Riham Bokhtia
Affiliation Faculty of Pharmacy, Zagazig University
Country Egypt
Scopus ID 57209660751
Documents 13
Citations 152
h-index 6
Subject Area Molecular
Event International Research Chemistry Awards
ORCID 0000-0001-5326-7364

Riham Bokhtia is affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, and has developed a research profile represented in international scholarly indexing systems. The available Scopus record identifies 13 documents, 152 citations, and an h-index of 6, providing quantitative indicators of publication activity and citation visibility. [1]

Abstract

Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy, Zagazig University, Egypt. Her scholarly profile is represented in the Scopus database by 13 indexed documents, 152 citations, and an h-index of 6. The available information places her research within the molecular subject area and provides a basis for describing her academic publication activity, research visibility. [1]

Keywords

Riham Bokhtia is a researcher affiliated with the Faculty of Pharmacy at Zagazig University, Egypt, with research interests spanning molecular chemistry. Her scholarly profile is represented through Scopus-indexed publications while her Scopus research profile provides indicators of scholarly impact. recognizing research contributions within chemistry and related scientific disciplines.[2]

Introduction

Academic research profiles provide a structured means of evaluating scholarly activity through publication records, citation patterns, and bibliometric indicators. Scopus is a major abstract and citation database used to index scholarly literature and to provide author-level indicators such as document counts, citation counts, and h-index values. [1]

Research Profile

The available bibliometric information identifies a documented research record associated with a Scopus Author profile. The indexed publications demonstrate scholarly activity and citation engagement, reflecting an established publication footprint and research visibility within the academic literature and broader scholarly presence in molecular research.[4]

Research Contributions

Bokhtia’s research profile is situated at the intersection of molecular science and pharmaceutical research. The molecular subject designation provides a broad indication of the scientific domain represented in the supplied academic record. Detailed assessment of individual research contributions should be based on the full-text publications and documented findings associated with each indexed work. [3]

Publications

For formal academic evaluation, the publication record can be reviewed through the researcher’s Scopus profile and, where available, individual publisher records and DOI registrations. These sources allow publication titles, journal information, publication years, authorship, citation metadata, and persistent identifiers to be verified independently. [4]

Research Impact

The reported 152 citations provide an observable indicator of scholarly use or discussion of the indexed documents, while the h-index of 6 indicates that at least six indexed publications have each received at least s ix citations under the relevant database calculation. Bibliometric indicators should, however, be interpreted alongside disciplinary norms. [2]

Award Suitability

On the supplied evidence, her profile demonstrates established scholarly activity through 13 Scopus-indexed documents, 152 citations, and an h-index of 6.  Final award assessment should additionally consider the originality, significance, quality, and documented scientific contribution of the underlying publications and any applicable award criteria. [3]

Conclusion

Riham Bokhtia’s academic profile reflects a documented research presence in the molecular and pharmaceutical research context. Her Scopus record reports 13 documents, 152 citations, and an h-index of 6, providing quantitative evidence of publication activity and citation visibility. These indicators support consideration of her scholarly profile within an academic recognition context. [4]

References

  1. Elsevier. (n.d.). Scopus author details: Riham Bokhtia, Author ID 57209660751. Scopus.
    https://www.scopus.com/pages/authors/57209660751
  2. ORCID. (n.d.). ORCID record for Riham Bokhtia.
    https://orcid.org/0000-0001-5326-7364
  3. International Research Chemistry Awards. (n.d.).
    https://researchchemistry.org
  4. Bokhtia, R. M., et al. (n.d.). Imidazole–sulfonamide hybrid conjugate: A privilege scaffold with significant therapeutic potential
    https://doi.org/10.1016/j.ejmcr.2025.100321

Dr. Véronique Eparvier | Chemistry of Natural Product | Best Researcher Award

Dr. Véronique Eparvier | Chemistry of Natural Product | Best Researcher Award

CNRS | France

Dr. Véronique Eparvier is a CNRS Research Director at the Institut de Chimie des Substances Naturelles (ICSN–CNRS) in France, where she leads the Functional Chemistry–Chemical Ecology team and serves as Deputy Coordinator of the Natural Substances–Medicinal Chemistry Department. She also established and manages the ICSN Symbiotic Microorganism Strain Library. She holds a PhD in Natural Products Chemistry and an Habilitation à Diriger des Recherches (HDR), along with Master’s degrees in Agro-resource Sciences and Anthropology. Her professional career spans over a decade of research at CNRS, including leading the “Chemodiversity of the Flora of French Guiana” program. Her research focuses on the interface of natural product chemistry, chemical ecology, and metabolomics, emphasizing interactions between microorganisms and plants or insects to identify bioactive metabolites of pharmacological and agrochemical interest and to elucidate their ecological roles. She applies integrative approaches combining analytical chemistry, metabolomic profiling, and ecological insights. Dr. Eparvier’s work has resulted in numerous publications, patents, conference presentations, and invited lectures. Her achievements have been recognized with awards such as the Air Liquide Trophy for Scientific Research. Through her research and outreach, she significantly advances knowledge in natural substances, chemical ecology, and interdisciplinary biotechnology.

Profiles: Scopus | Orcid

Featured Publications

Levasseur, M.; Santerre, C.; Segret, J.; Elie, N.; Genty, C.; Estevez, Y.; Amusant, N.; Houël, E.; Eparvier, V.; Touboul, D. (2023). “Composition of antifungal volatile organic compounds in Sextonia rubra fruit by molecular networks.” Comptes Rendus Chimie.

Hebra, T.; Eparvier, V.; Touboul, D. (2023). “Nitrogen Enriched Solid-State Cultivation for the Overproduction of Azaphilone Red Pigments by Penicillium sclerotiorum SNB-CN111.” Journal of Fungi.

Levasseur, M.; Hebra, T.; Elie, N.; Guérineau, V.; Touboul, D.; Eparvier, V. (2022). “Classification of Environmental Strains from Order to Genus Levels Using Lipid and Protein MALDI-ToF Fingerprintings and Chemotaxonomic Network Analysis.” Microorganisms.

Hebra, T.; Pollet, N.; Touboul, D.; Eparvier, V. (2022). “Combining OSMAC, metabolomic and genomic methods for the production and annotation of halogenated azaphilones and ilicicolins in termite symbiotic fungi.” Scientific Reports.

Hebra, T.; Pollet, N.; Touboul, D.; Eparvier, V. (2022). “Combining OSMAC, Metabolomic and Genomic Methods on Termite Symbiotic Fungi for the Production and Annotation of Halogenated Azaphilones and Ilicicolins.” Research Square, preprint.

Houël, E.; Ginouves, M.; Azas, N.; Bourreau, E.; Eparvier, V.; Hutter, S.; Knittel-Obrecht, A.; Jahn-Oyac, A.; Prévot, G.; Villa, P.; et al. (2022). “Treating leishmaniasis in Amazonia, part 2: Multi-target evaluation of widely used plants to understand medicinal practices.” Journal of Ethnopharmacology.

Sorres, J.; Hebra, T.; Elie, N.; Leman-Loubière, C.; Grayfer, T.; Grellier, P.; Touboul, D.; Stien, D.; Eparvier, V. (2022). “Antiparasitic Ovalicin Derivatives from Pseudallescheria boydii, a Mutualistic Fungus of French Guiana Termites.” Molecules.